Pre-existing clinical conditions as determinants of prognosis in SARS-CoV-2 infections
DOI:
https://doi.org/10.62452/ahdj2259Keywords:
Comorbidities, COVID-19, SARS-CoV-2, prognosis, risk factorsAbstract
SARS-CoV-2 infections have shown highly heterogeneous clinical behavior, largely influenced by preexisting comorbidities. This study examines the impact of conditions such as hypertension, diabetes mellitus, obesity, cardiovascular diseases, and chronic pulmonary disorders on the severity and outcomes of COVID-19. Based on a systematic review of recent studies, it is evident that these pathologies not only increase the risk of hospitalization, intensive care unit admission, and mortality but also influence immune responses and treatment efficacy. Early recognition of these conditions allows for more accurate risk stratification and the application of individualized clinical strategies. This research highlights the necessity of incorporating comorbidity assessment into COVID-19 patient management protocols, encouraging a preventive and predictive medical approach.
Downloads
References
Aguilar Ramírez, P., Enriquez Valencia, Y., Quiroz Carrillo, C., Valencia Ayala, E., de León Delgado, J., & Pareja Cruz, A. (2020). Pruebas diagnósticas para la COVID-19: la importancia del antes y el después. Horizonte Médico (Lima), 20(2), e1231. https://doi.org/10.24265/horizmed.2020.v20n2.14
Ahorsu, D. K., Lin, C.-Y., Imani, V., Saffari, M., Griffiths, M. D., & Pakpour, A. H. (2022). The fear of COVID-19 scale: Development and initial validation. International Journal of Mental Health and Addiction, 20(3), 1537–1545. http://dx.doi.org/10.1007/s11469-020-00270-8
Bettancourt Ortega, L., Cabrera-Cisternas, C., Castro-Rojas, A., Masnú-Berríos, S., Quiroz-Gallardo, F., Ruidíaz-Veliz, P., & Santana-Jorquera, N. (2023). Continuidad de los cuidados paliativos domiciliarios durante la pandemia por COVID-19. Horizonte de Enfermería. https://doi.org/10.7764/Horiz_Enferm.Num.esp.367-383
Ciotti, M., Ciccozzi, M., Terrinoni, A., Jiang, W.-C., Wang, C.-B., & Bernardini, S. (2020). The COVID-19 pandemic. Critical Reviews in Clinical Laboratory Sciences, 57(6), 365–388. http://dx.doi.org/10.1080/10408363.2020.1783198
Cummings, M. J., Baldwin, M. R., Abrams, D., Jacobson, S. D., Meyer, B. J., Balough, E. M., Aaron, J. G., Claassen, J., Rabbani, L. E., Hastie, J., Hochman, B. R., Salazar-Schicchi, J., Yip, N. H., Brodie, D., & O'Donnell, M. R. (2020). Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: A prospective cohort study. Lancet, 395(10239), 1763–1770. http://dx.doi.org/10.1016/S0140-6736(20)31189-2
Díaz, E., Amézaga Menéndez, R., Vidal Cortés, P., Escapa, M. G., Suberviola, B., Serrano Lázaro, A., Marcos Neira, P., Quintana Díaz, M., & Catalán González, M. (2020). Tratamiento farmacológico de la COVID-19: Revisión narrativa de los Grupos de Trabajo de Enfermedades Infecciosas y Sepsis (GTEIS) y del Grupo de Trabajo de Transfusiones Hemoderivados (GTTH). Medicina Intensiva, 45(2), 104–121. http://dx.doi.org/10.1016/j.medin.2020.06.017
Faour, W. H., Choaib, A., Issa, E., El Choueiry, F., Shbaklo, K., Alhajj, M., Sawaya, R. T., Harhous, Z., Alefishat, E., & Nader, M. (2022). Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies. Inflammation Research, 71(1), 39–56. http://dx.doi.org/10.1007/s00011-021-01520-8
García-Pachón, E., Zamora-Molina, L., Soler-Sempere, M. J., Baeza-Martínez, C., Grau-Delgado, J., Padilla-Navas, I., & Gutiérrez, F. (2020). Asthma and COPD in hospitalized COVID-19 patients. Archivos de Bronconeumología, 56(9), 604–606. http://dx.doi.org/10.1016/j.arbres.2020.05.007
Guzmán, V. (2021). El método cualitativo y su aporte a la investigación en las ciencias sociales. Revista Gestionar, 1(4), 19–31. http://dx.doi.org/10.35622/j.rg.2021.04.002
Jiménez Pérez, N. A., Fonseca Gómez, C. M., Fonseca Marrero, C. A., de la Paz Bermúdez, T., Martínez-Rodríguez, A., Herrera Marrero, N. L., … González Rubio, D. (2021). COVID-19: presentación clínica en pacientes hospitalizados en el Instituto de Medicina Tropical “Pedro Kourí”. Revista Cubana De Medicina Tropical, 73(1). https://revmedtropical.sld.cu/index.php/medtropical/article/view/603
Jin, J. M., Bai, P., He, W., Wu, F., Liu, X. F., Han, D. M., Liu, S., & Yang, J. K. (2020). Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Frontiers in public health, 8, 152. https://doi.org/10.3389/fpubh.2020.00152
Lascano Espinoza, D. P., Olivez Gracia, J. M., Durán Pincay, Y. E., & Quintanilla, M. (2022). Enfermedades hepáticas y COVID-19: Un problema de salud pública a nivel mundial. MQR Investigar, 6(3), 764–780. http://dx.doi.org/10.56048/mqr20225.6.3.2022.764-780
Lip, G., Coca, A., Kahan, T., Boriani, G., Manolis, A. S., Olsen, M. H., Oto, A., Potpara, T. S., Steffel, J., Marín, F., Figueiredo, M. J. de O., de Simone, G., Tzou, W. S., Chiang, C.-E., & Williams, B. (2017). Hypertension and cardiac arrhythmias: A consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE). Europace, 19(6), 891–911. http://dx.doi.org/10.1093/europace/eux091
Peñafiel-Chang, L., Camelli, G., & Peñafiel-Chang, P. (2020). Pandemia COVID-19: Situación política-económica y consecuencias sanitarias en América Latina. Ciencia Unemi, 13(33), 120–128. https://ojs.unemi.edu.ec/index.php/cienciaunemi/article/view/1118
Sanín-Blair, J. E., Muñoz-Velasquez, N., Mesa-Ramirez, V. M., Campo-Campo, M. N., Gutierrez-Marín, J. H., Rojas-Suárez, J. A., & Tolosa- Ardila, J. (2020). Enfermedad por coronavirus (COVID-19) en embarazo, parto y lactancia. CES Medicina, 34, 86–94. https://doi.org/10.21615/cesmedicina.34.COVID-19.12
Vosko, I., Zirlik, A., & Bugger, H. (2023). Impact of COVID-19 on cardiovascular disease. Viruses, 15(2). http://dx.doi.org/10.3390/v15020508
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Karen Estefanía Chaso-Pallango, Dayana Lorena Guaigua-Quingaluisa, María Ilusión Solís-Sánchez (Autor/a)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who publish in Revista Metropolitana de Ciencias Aplicadas (REMCA), agree to the following terms:
1. Copyright
Authors retain unrestricted copyright to their work. Authors grant the journal the right of first publication. To this end, they assign the journal non-exclusive exploitation rights (reproduction, distribution, public communication, and transformation). Authors may enter into additional agreements for the non-exclusive distribution of the version of the work published in the journal, provided that acknowledgment of its initial publication in this journal is given.
© The authors.
2. License
The articles are published in the journal under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0). The terms can be found at: https://creativecommons.org/licenses/by-nc-sa/4.0/deed.en
This license allows:
- Sharing: Copying and redistributing the material in any medium or format.
- Adapting: Remixing, transforming, and building upon the material.
Under the following terms:
- Attribution: You must give appropriate credit, provide a link to the license, and indicate if any changes were made. You may do this in any reasonable manner, but not in any way that suggests the licensor endorses or sponsors your use.
- NonCommercial: You may not use the material for commercial purposes.
- ShareAlike: If you remix, transform, or build upon the material, you must distribute your creation under the same license as the original work.
There are no additional restrictions. You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
